SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001457612-21-000063
Filing Date
2021-04-29
Accepted
2021-04-29 16:04:05
Documents
64
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q gnca-20210331.htm   iXBRL 10-Q 929436
2 EX-10.1 a2021q1ex101.htm EX-10.1 42290
3 EX-31.1 a2021q1ex311.htm EX-31.1 11824
4 EX-31.2 a2021q1ex312.htm EX-31.2 11466
5 EX-32 a2021q1ex32.htm EX-32 9291
11 gnca-20210331_g1.jpg GRAPHIC 16581
  Complete submission text file 0001457612-21-000063.txt   5137143

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT gnca-20210331.xsd EX-101.SCH 35687
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT gnca-20210331_cal.xml EX-101.CAL 56593
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT gnca-20210331_def.xml EX-101.DEF 202166
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT gnca-20210331_lab.xml EX-101.LAB 498041
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT gnca-20210331_pre.xml EX-101.PRE 330671
12 EXTRACTED XBRL INSTANCE DOCUMENT gnca-20210331_htm.xml XML 787124
Mailing Address 100 ACORN PARK DRIVE CAMBRIDGE MA 02140
Business Address 100 ACORN PARK DRIVE CAMBRIDGE MA 02140 617-876-8191
GENOCEA BIOSCIENCES, INC. (Filer) CIK: 0001457612 (see all company filings)

IRS No.: 510596811 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36289 | Film No.: 21870400
SIC: 2836 Biological Products, (No Diagnostic Substances)